Cargando…
Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group
BACKGROUND: The evaluation of immune response can aid in prediction of cancer behaviour. Here, we assessed the prognostic significance of tumour-infiltrating lymphocytes (TILs) in oropharyngeal squamous cell carcinoma (OPSCC). METHODS: A total of 182 patients treated for OPSCC were included in this...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130301/ https://www.ncbi.nlm.nih.gov/pubmed/35043007 http://dx.doi.org/10.1038/s41416-022-01708-7 |
_version_ | 1784712958686789632 |
---|---|
author | Almangush, Alhadi Jouhi, Lauri Atula, Timo Haglund, Caj Mäkitie, Antti A. Hagström, Jaana Leivo, Ilmo |
author_facet | Almangush, Alhadi Jouhi, Lauri Atula, Timo Haglund, Caj Mäkitie, Antti A. Hagström, Jaana Leivo, Ilmo |
author_sort | Almangush, Alhadi |
collection | PubMed |
description | BACKGROUND: The evaluation of immune response can aid in prediction of cancer behaviour. Here, we assessed the prognostic significance of tumour-infiltrating lymphocytes (TILs) in oropharyngeal squamous cell carcinoma (OPSCC). METHODS: A total of 182 patients treated for OPSCC were included in this study. Assessment of TILs was conducted on tumour sections stained with standard haematoxylin and eosin (HE) staining. We used the scoring criteria proposed by the International Immuno-Oncology Biomarker Working Group. RESULTS: The multivariable analysis showed that TILs associated with disease-specific survival with a hazard ratio (HR) of 2.13 (95% CI 1.14–3.96; P = 0.017). Similarly, TILs associated significantly with overall survival with HR of 1.87 (95% CI 1.11–3.13; P = 0.018). In a sub-analysis of HPV-positive and HPV-negative cases separately, TILs showed a significant prognostic value in both groups (P < 0.05). CONCLUSION: The evaluation of TILs as proposed by the International Immuno-Oncology Biomarker Working Group is a simple and promising method in prediction of survival of OPSCC. It is easily applicable and after further validation can be implemented in the routine pathological report as a basic immune parameter. |
format | Online Article Text |
id | pubmed-9130301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-91303012022-05-26 Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group Almangush, Alhadi Jouhi, Lauri Atula, Timo Haglund, Caj Mäkitie, Antti A. Hagström, Jaana Leivo, Ilmo Br J Cancer Article BACKGROUND: The evaluation of immune response can aid in prediction of cancer behaviour. Here, we assessed the prognostic significance of tumour-infiltrating lymphocytes (TILs) in oropharyngeal squamous cell carcinoma (OPSCC). METHODS: A total of 182 patients treated for OPSCC were included in this study. Assessment of TILs was conducted on tumour sections stained with standard haematoxylin and eosin (HE) staining. We used the scoring criteria proposed by the International Immuno-Oncology Biomarker Working Group. RESULTS: The multivariable analysis showed that TILs associated with disease-specific survival with a hazard ratio (HR) of 2.13 (95% CI 1.14–3.96; P = 0.017). Similarly, TILs associated significantly with overall survival with HR of 1.87 (95% CI 1.11–3.13; P = 0.018). In a sub-analysis of HPV-positive and HPV-negative cases separately, TILs showed a significant prognostic value in both groups (P < 0.05). CONCLUSION: The evaluation of TILs as proposed by the International Immuno-Oncology Biomarker Working Group is a simple and promising method in prediction of survival of OPSCC. It is easily applicable and after further validation can be implemented in the routine pathological report as a basic immune parameter. Nature Publishing Group UK 2022-01-18 2022-06-01 /pmc/articles/PMC9130301/ /pubmed/35043007 http://dx.doi.org/10.1038/s41416-022-01708-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Almangush, Alhadi Jouhi, Lauri Atula, Timo Haglund, Caj Mäkitie, Antti A. Hagström, Jaana Leivo, Ilmo Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group |
title | Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group |
title_full | Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group |
title_fullStr | Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group |
title_full_unstemmed | Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group |
title_short | Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group |
title_sort | tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the international immuno-oncology biomarker working group |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130301/ https://www.ncbi.nlm.nih.gov/pubmed/35043007 http://dx.doi.org/10.1038/s41416-022-01708-7 |
work_keys_str_mv | AT almangushalhadi tumourinfiltratinglymphocytesinoropharyngealcanceravalidationstudyaccordingtothecriteriaoftheinternationalimmunooncologybiomarkerworkinggroup AT jouhilauri tumourinfiltratinglymphocytesinoropharyngealcanceravalidationstudyaccordingtothecriteriaoftheinternationalimmunooncologybiomarkerworkinggroup AT atulatimo tumourinfiltratinglymphocytesinoropharyngealcanceravalidationstudyaccordingtothecriteriaoftheinternationalimmunooncologybiomarkerworkinggroup AT haglundcaj tumourinfiltratinglymphocytesinoropharyngealcanceravalidationstudyaccordingtothecriteriaoftheinternationalimmunooncologybiomarkerworkinggroup AT makitieanttia tumourinfiltratinglymphocytesinoropharyngealcanceravalidationstudyaccordingtothecriteriaoftheinternationalimmunooncologybiomarkerworkinggroup AT hagstromjaana tumourinfiltratinglymphocytesinoropharyngealcanceravalidationstudyaccordingtothecriteriaoftheinternationalimmunooncologybiomarkerworkinggroup AT leivoilmo tumourinfiltratinglymphocytesinoropharyngealcanceravalidationstudyaccordingtothecriteriaoftheinternationalimmunooncologybiomarkerworkinggroup |